TR200001961T2 - Ifnar 2/IFN kompleksi. - Google Patents

Ifnar 2/IFN kompleksi.

Info

Publication number
TR200001961T2
TR200001961T2 TR2000/01961T TR200001961T TR200001961T2 TR 200001961 T2 TR200001961 T2 TR 200001961T2 TR 2000/01961 T TR2000/01961 T TR 2000/01961T TR 200001961 T TR200001961 T TR 200001961T TR 200001961 T2 TR200001961 T2 TR 200001961T2
Authority
TR
Turkey
Prior art keywords
ifn
complex
ifnar
peptide
interferon
Prior art date
Application number
TR2000/01961T
Other languages
English (en)
Turkish (tr)
Inventor
Tepper Mark
Cunningham Mark
Sherris David
El Tayar Nabil
Mckenna Sean
Original Assignee
Applied Research Systems Ars Holding N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems Ars Holding N.V. filed Critical Applied Research Systems Ars Holding N.V.
Publication of TR200001961T2 publication Critical patent/TR200001961T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
TR2000/01961T 1997-12-19 1998-12-18 Ifnar 2/IFN kompleksi. TR200001961T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6829597P 1997-12-19 1997-12-19

Publications (1)

Publication Number Publication Date
TR200001961T2 true TR200001961T2 (tr) 2000-11-21

Family

ID=22081665

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/01961T TR200001961T2 (tr) 1997-12-19 1998-12-18 Ifnar 2/IFN kompleksi.

Country Status (27)

Country Link
US (1) US6372207B1 (enExample)
EP (1) EP1037658B1 (enExample)
JP (1) JP4601163B2 (enExample)
KR (1) KR100593981B1 (enExample)
CN (1) CN1241638C (enExample)
AR (1) AR020315A1 (enExample)
AT (1) ATE218362T1 (enExample)
AU (1) AU755078B2 (enExample)
BG (1) BG64920B1 (enExample)
BR (1) BR9813753A (enExample)
CA (1) CA2311648C (enExample)
DE (1) DE69805844T2 (enExample)
DK (1) DK1037658T3 (enExample)
EA (1) EA003635B1 (enExample)
EE (1) EE200000355A (enExample)
ES (1) ES2174530T3 (enExample)
HU (1) HUP0100456A3 (enExample)
IL (2) IL136855A0 (enExample)
NO (1) NO20002691L (enExample)
NZ (1) NZ504771A (enExample)
PL (1) PL197568B1 (enExample)
PT (1) PT1037658E (enExample)
SK (1) SK9222000A3 (enExample)
TR (1) TR200001961T2 (enExample)
UA (1) UA74132C2 (enExample)
WO (1) WO1999032141A1 (enExample)
ZA (1) ZA9811634B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL122818A0 (en) * 1997-07-10 1998-08-16 Yeda Res & Dev Chimeric interleukin-6 soluble receptor/ligand protein analogs thereof and uses thereof
AUPP670698A0 (en) * 1998-10-23 1998-11-19 Monash University A method of regulation
US7138379B2 (en) * 2000-07-26 2006-11-21 Schering Aktiengesellschaft Use of the interferon receptor 2c polypeptide chain to enhance the anti-growth effects of type I interferons
IL147414A0 (en) 2001-12-31 2002-08-14 Yeda Res & Dev Ifnar2 mutants, their production and use
US20040175359A1 (en) * 2002-11-12 2004-09-09 Desjarlais John Rudolph Novel proteins with antiviral, antineoplastic, and/or immunomodulatory activity
WO2005019260A1 (ja) * 2003-08-25 2005-03-03 Toray Industries, Inc. インターフェロンβ複合体
CN100400664C (zh) * 2005-09-06 2008-07-09 中国人民解放军第四军医大学 肿瘤血管导向肽与人干扰素α-2b的融合蛋白的制备方法
AU2007351813B2 (en) * 2006-10-31 2013-10-10 East Carolina University Fusion proteins comprising an anti-inflammatory cytokine and an antigen for treatment of immune disorders
GB0715383D0 (en) * 2007-08-08 2007-09-19 Asterion Ltd Interferon
GB0815216D0 (en) * 2008-08-21 2008-09-24 Asterion Ltd Interleukin
CA2757287C (en) 2009-03-31 2019-09-10 East Carolina University Cytokines and neuroantigens for treatment of immune disorders
KR101293363B1 (ko) * 2011-02-28 2013-08-05 성균관대학교산학협력단 인터페론 수용체 유전자를 포함하는 조류독감 예방용 조성물
US9902770B2 (en) * 2013-03-15 2018-02-27 Janssen Biotech, Inc. Interferon alpha and omega antibody antagonists
LT6164B (lt) 2013-10-15 2015-06-25 Uab Biotechnologinės Farmacijos Centras "Biotechpharma" Sulieti interferono-alfa 5 baltymai su kitu citokinu ir jų gamybos būdas
US20190241878A1 (en) 2016-07-01 2019-08-08 Resolve Therapeutics, Llc Optimized binuclease fusions and methods
CA3067539A1 (en) * 2017-06-20 2018-12-27 The Board Of Regents Of The University Of Texas System Interferon prodrug for the treatment of cancer
CA3073537A1 (en) 2017-08-22 2019-02-28 Sanabio, Llc Soluble interferon receptors and uses thereof
CN112646783B (zh) * 2020-12-30 2023-12-01 广州医科大学附属市八医院 表达基因、经基因修饰的受精卵的构建方法和小鼠模型的构建方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL106591A (en) 1992-09-03 2008-03-20 Yeda Res & Dev Interferon alpha/beta binding protein, its preparation and pharmaceutical compositions containing it
US5821078A (en) * 1992-09-03 1998-10-13 Yeda Research And Development Co. Ltd. Nucleic acid encoding interferon-α/β binding protein
IL107378A (en) * 1993-10-24 2005-05-17 Yeda Res & Dev SOLUBLE INTERFERON alpha-RECEPTOR, ITS PREPARATION AND USE

Also Published As

Publication number Publication date
NO20002691D0 (no) 2000-05-25
PL197568B1 (pl) 2008-04-30
NZ504771A (en) 2002-09-27
US6372207B1 (en) 2002-04-16
DK1037658T3 (da) 2002-09-30
DE69805844D1 (de) 2002-07-11
KR100593981B1 (ko) 2006-06-30
ATE218362T1 (de) 2002-06-15
IL136855A0 (en) 2001-06-14
JP2001526242A (ja) 2001-12-18
PT1037658E (pt) 2002-10-31
HUP0100456A3 (en) 2003-09-29
SK9222000A3 (en) 2001-01-18
EA003635B1 (ru) 2003-08-28
BR9813753A (pt) 2000-10-10
BG64920B1 (bg) 2006-09-29
EE200000355A (et) 2001-10-15
ES2174530T3 (es) 2002-11-01
ZA9811634B (en) 1999-06-22
KR20010032836A (ko) 2001-04-25
UA74132C2 (uk) 2005-11-15
IL136855A (en) 2007-07-24
AU755078B2 (en) 2002-12-05
CN1241638C (zh) 2006-02-15
PL341423A1 (en) 2001-04-09
EA200000685A1 (ru) 2000-12-25
NO20002691L (no) 2000-08-18
AR020315A1 (es) 2002-05-08
EP1037658A1 (en) 2000-09-27
EP1037658B1 (en) 2002-06-05
AU1926999A (en) 1999-07-12
CA2311648C (en) 2010-11-16
CN1282255A (zh) 2001-01-31
WO1999032141A1 (en) 1999-07-01
BG104539A (en) 2001-04-30
DE69805844T2 (de) 2002-10-24
CA2311648A1 (en) 1999-07-01
JP4601163B2 (ja) 2010-12-22
HK1032914A1 (en) 2001-08-10
HUP0100456A1 (hu) 2001-06-28

Similar Documents

Publication Publication Date Title
TR200001961T2 (tr) Ifnar 2/IFN kompleksi.
DE60000665D1 (de) Lang wirkende peptidinhibitoren der virusfusion mit körperzellen bei viralen infektionen
DE69807679D1 (de) Zusammensetzungen aus konjugaten des stabilen, aktiven, menschlichen ob proteins mit der fc kette von immunoglobulinen und damit zusammenhängende verfahren
IL152886A0 (en) B-7 related nucleic acids and polypeptides and pharmaceutical compositions containing the same
TR200003161T2 (tr) Poliol-IFN-Beta konjugatları
NO20015584D0 (no) Lantidsvarende insulintrofiske peptider
WO2002010195A3 (en) Modified peptides with increased potency
DE69435105D1 (de) Derivate therapeutischer Peptide
CY1114030T1 (el) Ομοιογενη παρασκευασματα toy il-29
IL147293A0 (en) Peptides that lower blood glucose levels
MXPA02000465A (es) Derivados ciclopeptidicos como inhibidores de la integrina alfav beta6.
ATE172216T1 (de) Konjugate von calcitonin und polyethylenglycol
DE69328035D1 (de) Polypeptide, von endonexin 2 stammend, mit hepatitis b virus rezeptor aktivität und deren verwendungen in diagnotischen und pharmazeutischen zusammensetzungen
TR199901190T2 (xx) Interferon-(alfa) N�kleik asitlerinin verilmesi ve sentezlenmesi i�in y�ntemler ve bile�imler.
LV11816A (lv) Implantejama zalu forma
EA200000270A1 (ru) КОМПОЗИЦИИ ДЛЯ ГЕНОТЕРАПИИ С ИСПОЛЬЗОВАНИЕМ ГЕНОВ, КОДИРУЮЩИХ СЕКРЕТИРУЕМЫЕ БЕЛКИ, ТАКИЕ КАК β-ИНТЕРФЕРОН, И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
TR200000416T2 (tr) Neisseria loctoferrin bağlayıcı protein.
EP1892251A3 (en) B7-related nucleic acids and polypeptides and their uses for immunomodulation
EA200001252A1 (ru) КОМПОЗИЦИЯ РЕКОМБИНАНТНОГО ИНТЕРФЕРОНА-β-1A(IFN-β-1A) ЧЕЛОВЕКА
ATE347899T1 (de) Interferon nachahmende peptide und rekombinante proteine
NZ513915A (en) Chimeric proteins comprising 6 contiguous amino acids that bind to the GIT fused to a second protein, which may be a drug
KR930002375A (ko) 리보톡신류의 단백질